Advertisement

Gene Therapy News: Breaking Gene Therapy News, Comments and Articles. - Page: 2

11:06 EDT 21st May 2013 | BioPortfolio

Gene Therapy News - Page: 2 RSSTwitter

Read the latest Gene Therapy News from around the world, updated every five minutes. Breaking stories from leading news and press agencies, bloggers and experts on Gene Therapy.

Search or Follow Our Gene Therapy - Page: 2 News…

If you are looking for more stories, you may wish to search our extensive news archives for relevant stories: Search for More Gene Therapy - Page: 2 News.
You can also follow our Gene Therapy - Page: 2 news stories on Twitter: @TherapyGene

Showing "gene therapy" News Articles 26 to 50 of 18,000+

Tuesday 21st May 2013

Marketing Expert Shows to Physical Therapists How Billing Becomes a Breeze with Simplified Billing Software

Nitin Chhoda, an international private practice marketing expert, recently released information showing how coding, billing, reconciling accounts, are all streamlined with easy to use physical therapy billing software. Denville, NJ (PRWEB) May 21, 2013 Licensed physical therapist, Nitin Chhoda, has created a dynamic solution to streamline physical therapists private practice billing process. It...

Allergan, Mentor and Galderma Lead the Accelerating European Market for Cosmetic Surgery, Facial Aesthetics and Medical Lasers Reports iData Research Inc.

Increasing demand for affordable, minimally invasive products and name-brand recognition is driving cosmetic device sales in Europe, particularly the botulinum toxin A market. Vancouver, BC (PRWEB) May 21, 2013 According to a new report series by iData Research, the total European market for cosmetic surgery, facial aesthetics and medical laser devices is valued at €869.4 million.This market in...

Study puts Huntington's disease trials on TRACK

(Medical Xpress)—A three-year multinational study has tracked and detailed the progression of Huntington's disease (HD), predicting clinical decline in people carrying the HD gene more than 10 years before the expected onset of symptoms.

No silence about RNA silencing

FSANZ: Response to Heinemann et al on the regulation of GM crops and foods developed using gene silencing(May 2013)Key pointsA recent scientific article (Heinemann et al, 2013) claims that small double-stranded RNAs (dsRNAs) generated in GM plants as a result of using gene silencing techniques can create biosafety risks that are not being adequately assessed by regulators such as Food Standards Au...

OrbusNeich seizes Boston Scientific stents in Germany as part of patent infringement proceedings

WIESBADEN, Germany, May 21, 2013 /PRNewswire/ -- Medical device manufacturer OrbusNeich Medical Inc. and its subsidiary, OrbusNeich Medical GmbH (collectively "OrbusNeich") today announced that it has enforced the seizure of over 190 stent systems from Boston Scientific Corporation (NYSE: BSX) in connection with its patent infringement proceedings in the Dusseldorf Regional Court. The product...

Pilot Program To Perform Genetic Testing For Breast, Ovarian Cancers

Brett Smith for redOrbit.com - Your Universe Online As part of a public-private collaboration, a UK-based charitable foundation has announced a pilot program to genetically test patients for breast and ovarian cancer. “Recent advances in methods for reading the genetic code, known as sequencing, mean that looking for gene mutations is now faster and more affordable than ever before,” accordi...

Verrata™ Pressure Guide Wire and iFR® (Instant Wave-Free Ratio™) Software Modality will be on display at EuroPCR 2013[1]

SAN DIEGO, May 21, 2013 /PRNewswire/ -- Volcano Corporation (NASDAQ: VOLC) a leading developer and manufacturer of precision guided therapy tools designed to enhance the diagnosis and treatment of coronary and peripheral vascular disease, today announced that it will demonstrate the Verrata™ Pressure Guide Wire and the iFR® (Instant wave-Free Ratio™) modality throughout the w...

Sugar Injections for Knee Arthritis May Ease Pain: Study

By Steven Reinberg HealthDay Reporter MONDAY, May 20 (HealthDay News) -- Injections of a sugar solution appear to help relieve knee pain and stiffness related to osteoarthritis, a new study suggests. The technique -- known as dextros...

Newer, Pricier Prostate Cancer Radiation No Better Than Old: Study

By Amy Norton HealthDay Reporter MONDAY, May 20 (HealthDay News) -- The costly form of radiation therapy that has become the norm for prostate cancer in the United States may be no better than the older, cheaper variety -- at least fo...

Researchers say that receiving cancer radiation therapy late in the day may minimize hair loss

Discovering that mouse hair has a circadian clock - a 24-hour cycle of growth followed by restorative repair - researchers suspect that hair loss in humans from toxic cancer radiotherapy and chemotherapy might be minimized if these treatments are giv...

Researchers develop new mouse model to discover gene pathways that drive MPNST

University of Minnesota Medical School researchers from the Masonic Cancer Center, University of Minnesota, in partnership with the University's Brain Tumor Program, have developed a new mouse model of malignant peripheral nerve sheath tumors that al...

Monday 20th May 2013

UCLA study: Older men with multiple underlying health problems should avoid prostate cancer treatment

Older prostate cancer patients with other underlying health conditions should think twice before committing to surgery or radiation therapy for their cancer, according to a multicenter study led by researchers in the UCLA Department of Urology.

UTMB researchers awarded grant to study gene therapy techniques to eliminate neuropathic pain

University of Texas Medical Branch at Galveston researchers have been awarded a five-year, $1.8 million grant by the National Institute of Neurological Disorders and Stroke to apply the techniques of gene therapy to the problem of neuropathic pain -...

Ferumoxytol Treatment Produced Significant Hemoglobin Increases in Adult Iron Deficiency Anemia Patients With Gastrointestinal Disease Who Had Failed or Could Not Tolerate Oral Iron Therapy

LEXINGTON, Mass., May 21, 2013 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (Nasdaq:AMAG) announced that a new sub-group analysis from IDA-301, a phase III, randomized, placebo-controlled clinical trial, will be presented today at a poster session of the Digestive Disease Week 2013 (DDW) meeting in Orlando, Florida. In the full IDA-301 study, 608 adult patients with iron deficiency anemia (IDA)...

Timing of cancer radiation therapy may minimize hair loss

Discovering that mouse hair has a circadian clock – a 24-hour cycle of growth followed by restorative repair – researchers suspect that hair loss in humans from toxic cancer radiotherapy...

Antibiotic therapy appears beneficial for patients with COPD

(American Thoracic Society) Extended use of a common antibiotic may prolong the time between hospitalizations for patients suffering from chronic obstructive pulmonary disease, according to a post-hoc analysis of a multicenter study which compared th...

Multiple Target ALS Drug Ready for Genervon's Phase 2 Trial

Multiple targets, highly effective, breakthrough therapy for ALS sufferers may now be within reach. Winston Ko, the CEO of Genervon Biopharmaceuticals, will be presenting on Friday at the Neurotech Conference in San Francisco that its endogenous regulatory drug GM604 modulates over 80 ALS related gene targets interactively and dynamically through 12 pathwa...

Androgen-deprivation therapy in men with metastatic prostate cancer: less may not necessarily be more

Volcano to Highlight its Physiology Expansion Efforts at EuroPCR 2013

SAN DIEGO, May 20, 2013 /PRNewswire/ -- Volcano Corporation (NASDAQ: VOLC) a leading developer and manufacturer of precision guided therapy tools designed to enhance the diagnosis and treatment of coronary and peripheral vascular disease, today announced it will highlight its efforts to expand research and innovation surrounding its physiology technologies, including its Fractional Flo...

Characterization of a novel swollenin from Penicillium oxalicum in facilitating enzymatic saccharification of cellulose

Background: Plant expansins and fungal swollenin that can disrupt crystalline cellulose have great potential for applications in conversion of biomass. Recent studies have been mainly focused on Trichoderma reesei swollenin that show relatively low a...

Factors influencing the efficiency of generating genetically engineered pigs by nuclear transfer: multi-factorial analysis of a large data set

Background: Somatic cell nuclear transfer (SCNT) using genetically engineered donor cells is currently the most widely used strategy to generate tailored pig models for biomedical research. Although this approach facilitates a similar spectrum of gen...

IMRT Benefits in Prostate Cancer Questioned (CME/CE)

(MedPage Today) -- Men with prostate cancer gained no obvious benefits from treatment with intensity-modulated radiation therapy (IMRT) as compared with an older, less expensive technique, an analysis of a government database suggests.

Apigenin: The compound in the Mediterranean diet that makes cancer cells ‘mortal’

New research suggests that a compound abundant in the Mediterranean diet takes away cancer cells’ “superpower” to escape death. By altering a very specific step in gene regulation,...

Researchers develop model for better testing, targeting of malignant peripheral nerve sheath tumors

University of Minnesota Medical School researchers from the Masonic Cancer Center, University of Minnesota, in partnership with the University's Brain Tumor Program, have developed a new mouse model of malignant peripheral nerve sheath tumors (MPNST)...

Lung cancer gene test approved as 'companion diagnostic'

The US medicines regulator, the Food and Drug Administration, has approved a genetic test to help doctors select suitable lung cancer patients to be treated with the drug erlotinib...


Search BioPortfolio:
Advertisement

News Quicklinks

Advertisement